Clinical trials
Hallucinations trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 7 |
| Not yet recruiting | 3 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 6 |
| Columbia University | 3 |
| University of North Carolina, Chapel Hill | 3 |
| VA Office of Research and Development | 2 |
| Beth Israel Deaconess Medical Center | 1 |
| Boston VA Research Institute, Inc. | 1 |
| Brian A Coffman, PhD | 1 |
| Harvard Medical School (HMS and HSDM) | 1 |
| Manhattan Psychiatric Center | 1 |
| National Institute of Mental Health (NIMH) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hallucinations | 28 |
| Schizophrenia | 23 |
| Psychotic Disorders | 12 |
| Alzheimer Disease | 1 |
| Dementia | 1 |
| Mental Disorders | 1 |
| Paranoid Disorders | 1 |
| Psychomotor Agitation | 1 |
| Schizophrenia, Treatment-Resistant | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.